An Van den Bergh

1.5k total citations
30 papers, 960 citations indexed

About

An Van den Bergh is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, An Van den Bergh has authored 30 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in An Van den Bergh's work include Cardiovascular Function and Risk Factors (8 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). An Van den Bergh is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). An Van den Bergh collaborates with scholars based in Belgium, United States and Germany. An Van den Bergh's co-authors include Paul Herijgers, Willem Flameng, Ghislaine Gayan‐Ramirez, Marc Decramer, Erik Verbeken, Karen Maes, Sofie Janssen, Jan D’hooge, Gerry Van der Mieren and André La Gerche and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Medicinal Chemistry.

In The Last Decade

An Van den Bergh

30 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
An Van den Bergh Belgium	15	439	336	137	102	102	30	960
Gerald Wölkart Austria	18	322 0.7×	258 0.8×	383 2.8×	126 1.2×	63 0.6×	40	961
Hiroko Satoh Japan	17	116 0.3×	264 0.8×	155 1.1×	114 1.1×	32 0.3×	40	937
Fei He China	16	210 0.5×	398 1.2×	75 0.5×	88 0.9×	50 0.5×	33	931
Signe T. Andersen Denmark	15	97 0.2×	216 0.6×	406 3.0×	85 0.8×	45 0.4×	29	919
Szilvia Török Hungary	17	90 0.2×	330 1.0×	125 0.9×	146 1.4×	64 0.6×	43	917
Nathan Robbins United States	16	229 0.5×	274 0.8×	110 0.8×	112 1.1×	41 0.4×	34	778
Wei Ji China	18	75 0.2×	236 0.7×	194 1.4×	73 0.7×	80 0.8×	67	828
N. Christophidis Australia	16	99 0.2×	201 0.6×	246 1.8×	86 0.8×	82 0.8×	34	1.1k
Gang Yuan China	17	332 0.8×	268 0.8×	312 2.3×	157 1.5×	44 0.4×	40	1.4k
Ramesh Boinpally United States	19	95 0.2×	219 0.7×	179 1.3×	132 1.3×	207 2.0×	86	1.2k

Countries citing papers authored by An Van den Bergh

Since Specialization

Citations

This map shows the geographic impact of An Van den Bergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Van den Bergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Van den Bergh more than expected).

Fields of papers citing papers by An Van den Bergh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Van den Bergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Van den Bergh. The network helps show where An Van den Bergh may publish in the future.

Co-authorship network of co-authors of An Van den Bergh

This figure shows the co-authorship network connecting the top 25 collaborators of An Van den Bergh. A scholar is included among the top collaborators of An Van den Bergh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Van den Bergh. An Van den Bergh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Snoeys, Jan, Marjolein van Heerden, An Van den Bergh, et al.. (2025). Human organotypic colon in vitro microtissue: unveiling a new window into colonic drug disposition. European Journal of Pharmaceutical Sciences. 209. 107025–107025. 2 indexed citations

Rompaey, Dries Van, Mazen Ahmad, Justin S. Cisar, et al.. (2024). Toward Dose Prediction at Point of Design. Journal of Medicinal Chemistry. 67(24). 22282–22290. 5 indexed citations

Rompaey, Dries Van, Denise Morrison, An Van den Bergh, & Jörg K. Wegner. (2023). A Symbolic Regression Model for the Prediction of Drug Binding to Human Liver Microsomes. Molecular Pharmaceutics. 20(5). 2436–2442. 3 indexed citations

Zane, Patricia, Hille Gieschen, Neil Mathias, et al.. (2019). In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development. European Journal of Pharmaceutics and Biopharmaceutics. 142. 222–231. 19 indexed citations

Stillhart, Cordula, Xavier Pépin, Christophe Tistaert, et al.. (2019). PBPK Absorption Modeling: Establishing the In Vitro–In Vivo Link—Industry Perspective. The AAPS Journal. 21(2). 19–19. 62 indexed citations

Bolla, M., P. Maingon, An Van den Bergh, et al.. (2014). 02 Results of EORTC 22991: 3D-CRT/IMRT with or without 6-month androgen deprivation therapy in localized T1b-cT2aN0M0 prostate cancer (EORTC 22991). European Urology Supplements. 13(5). 104–105. 2 indexed citations

Nevelsteen, Ines, An Van den Bergh, Gerry Van der Mieren, et al.. (2013). NO-Dependent Endothelial Dysfunction in Type II Diabetes Is Aggravated by Dyslipidemia and Hypertension, but Can Be Restored by Angiotensin-Converting Enzyme Inhibition and Weight Loss. Journal of Vascular Research. 50(6). 486–497. 19 indexed citations

Bergh, An Van den, Vikash Sinha, Ron Gilissen, et al.. (2011). Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data. Clinical Pharmacokinetics. 50(8). 505–517. 23 indexed citations

Mathar, Ilka, Rudi Vennekens, Marcel Meissner, et al.. (2010). Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. Journal of Clinical Investigation. 120(9). 3267–3279. 127 indexed citations

10.

Bergh, An Van den, Peter Vangheluwe, Annelies Vanderper, et al.. (2009). Food-Restriction in Obese Dyslipidaemic Diabetic Mice Partially Restores Basal Contractility but not Contractile Reserve. European Journal of Heart Failure. 11(12). 1118–1125. 12 indexed citations

11.

Buyse, Gunnar, Nathalie Goemans, Gerry Van der Mieren, et al.. (2008). T.O.3 SNT-MC17/idebenone in Duchenne muscular dystrophy: long-term blinded controlled preclinical study in the mdx mouse followed by a 12 month double-blind randomized controlled trial in humans. Neuromuscular Disorders. 18(9-10). 832–832. 1 indexed citations

12.

Buyse, Gunnar, Gerry Van der Mieren, Michael A. Erb, et al.. (2008). Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. European Heart Journal. 30(1). 116–124. 82 indexed citations

13.

Raeymaekers, Luc, et al.. (2007). Apoptosis levels of CD34+cells after induced DNA damage: Measurement of DNA fragmentation in different annexin V-affinity fractions of sorted CD34+cells using the DNA diffusion assay and comet assay. Acta Clinica Belgica. 62(4). 264–264. 1 indexed citations

14.

Pokreisz, Péter, Marijke Pellens, An Van den Bergh, et al.. (2007). Cardiomyocyte-specific overexpression of type 5 phosphodiesterase impairs postinfarction myocardial function and left ventricular remodeling. Circulation. 116(16). 45–46. 4 indexed citations

15.

Bergh, An Van den, Annelies Vanderper, Peter Vangheluwe, et al.. (2007). Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovascular Research. 77(2). 371–379. 64 indexed citations

16.

Bergh, An Van den, Willem Flameng, & Paul Herijgers. (2007). Parameters of ventricular contractility in mice: influence of load and sensitivity to changes in inotropic state. Pflügers Archiv - European Journal of Physiology. 455(6). 987–994. 32 indexed citations

17.

Bergh, An Van den, Willem Flameng, & Paul Herijgers. (2006). Type II Diabetic Mice Exhibit Contractile Dysfunction but Maintain Cardiac Output by Favourable Loading Conditions. European Journal of Heart Failure. 8(8). 777–783. 53 indexed citations

18.

Vangheluwe, Peter, Marc Tjwa, An Van den Bergh, et al.. (2006). A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span. Journal of Molecular and Cellular Cardiology. 41(2). 308–317. 45 indexed citations

19.

Bergh, An Van den, et al.. (1998). The examination of the reliability and validity of the LASSI for the assessment of developing students' learning and study strategies in the RSA. South African Journal of Higher Education. 12(3). 159–166. 3 indexed citations

20.

Vallbo, Christina, Tommy Bergenheim, An Van den Bergh, Kjell Grankvist, & Roger Henriksson. (1995). DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain - suggesting an apoptotic cell death. British Journal of Cancer. 71(4). 717–720. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact